Effects of human growth hormone in men over 60 years old.

Human Clinical1990clinical trial (older men, 6 months)HGH Somatropin

Rudman D, Feller AG, Nagraj HS, et al. · New England Journal of Medicine

Abstract / Summary

Six months of recombinant human growth hormone in healthy men over 60 increased lean body mass and reduced adipose tissue, the landmark observation that triggered subsequent investigation of GH in age-related body composition change.

Methods

Investigated as a clinical trial (older men, 6 months) in the field of endocrine research. The study design follows the methodology described in the published manuscript indexed under the identifiers listed above. Full methodological detail is available in the source publication via the PubMed or DOI link.

Results

Six months of recombinant human growth hormone in healthy men over 60 increased lean body mass and reduced adipose tissue, the landmark observation that triggered subsequent investigation of GH in age-related body composition change.

Limitations

Short duration, small sample, no long-term safety follow-up; subsequent literature has highlighted significant adverse effects (oedema, arthralgia, glucose intolerance) limiting any anti-ageing application.

External links